What Jeff Yuen & Associates does

Jeff Yuen & Associates, Inc. (JYA) is a privately held pharmaceutical quality and regulatory compliance consulting firm founded in 1998 by CDR Jeff Yuen after his departure from the US FDA, where he had served as Commander in the US Public Health Service and as Los Angeles District Pre-Approval Manager. The firm is headquartered in Wilmington, North Carolina (with an additional contact office in New York), and operates on a global basis via direct consulting engagements and an affiliate network spanning the US, UK, Germany, Japan, and other markets. Its core service portfolio covers audits and mock inspections, validation/commissioning/qualification, executive quality leadership and interim placements, air flow visualization (smoke studies), regulatory affairs and submissions, Qualified Person (QP) services for Europe, project management, training, and expert witness testimony. Areas of expertise span cell and gene therapy, drug substance/API, computer software validation and data integrity, GLP/GCP/BIMO, QC/laboratory support, medical devices and combination products, pharmacovigilance, compounding pharmacies (503A/503B), and technical writing.

The underlying technology is human expertise rather than a software platform; the firm's value proposition rests on a team whose principals average more than 30 years of industry experience and whose former regulators average more than 20 years inside health authorities, with 2,000+ cumulative industry years and 350+ cumulative health-authority years across the bench. There is no proprietary software, AI/ML product, or data asset disclosed; service delivery relies on senior consultants and a network of specialty affiliates (QACV, Micro-Reliance, Pharmefex, Sage Biopartners, Dahlia Consulting, Longview Leader, and CM Plus) brought in on a project basis.

JYA makes money through professional services engagements — billable project work and hourly or retainer-based consulting contracts sold directly to enterprise pharma, biotech, biologics, medical device, gene therapy, compounding pharmacy, and CMO clients, plus repeat referrals from its 750+ client base. Customer acquisition is driven by referral, industry reputation, LinkedIn presence, conference participation, and the firm's website, with no public pricing and no paid advertising. The firm has no external investors, no parent company, and no disclosed funding; ownership remains concentrated with the founding family (CEO Jeff Yuen and CFO/co-founder Lynnette Yuen), with named partners and executive directors contributing to leadership.

Name

Jeff Yuen & Associates

Legal name

Jeff Yuen & Associates, Inc.

Website

https://jeffyuen.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Jeff Yuen & Associates is a private pharma quality and regulatory consulting firm founded in 1998, advising pharmaceutical, biologics, biotech, gene therapy, and medical device clients on FDA inspection readiness, GxP compliance, validation, and regulatory submissions via former FDA, MHRA, PMDA, and Health Canada personnel.

Ownership category

akta.pro rank

Product category

Pharmaceutical Quality Consulting

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical quality consulting
• Regulatory compliance services
• FDA inspection preparation
• GMP audit consulting
• Biologics consulting services

Headquarters

HQ city

Orange

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Consulting Services: Professional consulting services billed at project or hourly rates. Services include audits and mock inspections, validation and commissioning, regulatory affairs support, training, QP services, project management, and expert witness testimony. Revenue is generated through client engagements that are typically project-based or retainer arrangements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Jeff Yuen & Associates is a pharmaceutical and biologics quality consulting firm that delivers FDA inspection readiness, mock inspections, gap assessments, validation and commissioning, regulatory affairs and submission support, executive quality leadership, training, and expert witness testimony. The firm serves pharmaceutical, biotech, biologics, and medical device companies across pre-clinical, clinical, and commercial phases, using senior former regulators (FDA, MHRA, PMDA, Health Canada) and industry executives as consultants.

Product overview

Jeff Yuen & Associates is a pharmaceutical and biologics quality consulting firm established in 1998. The company offers a comprehensive portfolio of consulting services organized around core offerings including Audits and Mock Inspections, Validation/Commissioning/Qualification, Executive Quality Leadership, Air Flow Visualization (smoke studies), Training, Regulatory Affairs & Submissions, Qualified Person (QP) Services, Project Management, and Expert Witness services. These services are delivered across multiple areas of expertise including Cell and Gene Therapy, Drug Substance/API, Computer Software Validation/Data Integrity, GLP/GCP/BIMO, QC/Laboratory Support, Medical Devices/Combination Products, Pharmacovigilance, Compounding Pharmacies, and Documentation Management. The firm combines former health authority regulators (FDA, MHRA, PMDA, Health Canada) with industry experts to provide inspection readiness, compliance remediation, and regulatory submission support for pharmaceutical, biotech, and medical device companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Audits and Mock Inspections Comprehensive audit services including gap assessments, mock inspections, internal audits of quality units, FDA 483 response preparation, sponsor oversight, and due diligence for mergers and acquisitions. Covers all GxP areas including GLP, GCP, GMP, and Combination Products, targeting pharmaceutical, biotech, and medical device companies preparing for regulatory inspections.
• Validation, Commissioning and Qualification Facility design, construction, commissioning, and validation services including facility, equipment, process, and cleaning validations compliant with US, EU, and international requirements, intended for pharmaceutical manufacturers building or remediating facilities.
• Executive Quality Leadership / Mentorship and Management Support Executive leadership and mentorship to site leaders in governance, CGMP compliance, quality metrics, KPIs, deviation management, and significant compliance issues, including interim senior quality and operations leadership roles for pharmaceutical and biotech clients.
• Air Flow Visualization Smoke studies for contamination control and sterility assurance, including protocol development, on-site training, equipment selection, tracer particle visualization, and comprehensive reporting for regulatory compliance in sterile manufacturing environments.
• Training CGMP foundation training including aseptic processing coaching, contamination control, facilities, critical utilities, equipment qualification, regulatory affairs, CMC, and process development training for pharmaceutical and biotech client teams.
• Regulatory Affairs & Submissions Regulatory strategy, FDA communications, operations and publishing, labeling, CMC, post-marketing, and non-clinical/clinical support. Handles NDAs, NADAs, ANDAs, DMFs, and FDA regulatory meetings, and provides US Agent services for FDA communications.
• Qualified Person (QP) Services European market support through UK and Germany-based Qualified Persons for qualification audits, due diligence, and batch release needs for clinical and commercial drug products seeking EU market access.
• Project Management Top-tier project management for product approval processes, facility construction, capital expansions, validations, and remediation projects, including governance plans, dashboards, and communication and escalation plans.
• Expert Witness Expert witness services for legal situations requiring pharmaceutical regulatory and GMP compliance testimony from senior former regulators and industry executives.
• Cell and Gene Therapy Consulting Consulting for CAR-T, monoclonal antibodies, viral vectors, recombinant proteins, and biosimilars, combining former FDA Team Biologics members with industry leaders for regulatory guidance and inspection readiness.
• Drug Substance / API Consulting Support for traditional APIs, fermented drug substances, critical starting materials, and plasmids across small and large pharmaceutical manufacturers.
• Computer Software Validation / Data Integrity / Part 11 Compliance Data integrity, CFR Part 11, computer system validation (CSV), and Computer Software Assurance (CSA) services to ensure regulatory compliance and inspection readiness for pharmaceutical clients.
• GLP / GCP / BIMO / Data Integrity

Quantifiable outcome

• Helped client achieve zero observations on FDA Pre-Approval Inspection (PAI)
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered minor.

• Micro-Reliance, LLCminorImplementation/ SI/ Consulting PartnerExpert Microbiological Consulting led by Ken Muhvich, Ph.D. (ex-FDA). Provides microbiology and sterility assurance expertise for pharmaceutical and biopharmaceutical facilities.
• Pharmefex LLCminorImplementation/ SI/ Consulting PartnerCell Therapy and Biologics Consulting. Specialist consulting firm for cell therapy and biologics development and manufacturing.
• Dahlia ConsultingminorImplementation/ SI/ Consulting PartnerProject Management and Consulting Services. Provides project management expertise for life sciences consulting engagements.
• Sage BiopartnersminorImplementation/ SI/ Consulting PartnerSpecialists in Medical Device and Combination Products. Co-founded by Moj Eram, Ph.D., Senior Associate at JYA. Focus on quality and regulatory affairs for medical devices and combination products.
• Longview LeaderminorImplementation/ SI/ Consulting PartnerHelping clients navigate the intersection of strategy and risk management. Specialist in enterprise risk and compliance consulting.
• CM PlusminorImplementation/ SI/ Consulting PartnerEngineering and Consulting for the Life Sciences Industry. Japanese-based engineering and consulting firm providing support with Japanese language capabilities for JYA clients.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ProPharma Group: Pharma, biotech, and medical device compliance consulting firm offering quality, regulatory, and pharmacovigilance services. Comparable in client mix (pharma/biotech) and service categories (audits, mock inspections, regulatory affairs, validation).
• Lachman Consultants: Long-standing boutique pharmaceutical quality and regulatory compliance consultancy serving pharma, biotech, and medical device companies with FDA inspection readiness, GMP audits, and remediation services — the most direct competitor to JYA in the US niche quality consulting space.
• CfPIE (Center for Professional Innovation and Education): Provider of GMP, regulatory, and quality training plus compliance consulting to pharma and biotech professionals. Comparable in training and CGMP coaching offerings, though more focused on training delivery than end-to-end consulting.
• Concordia Valsource (formerly Valsource): Specialized pharma validation, commissioning, and qualification consultancy; merger with Concordia expanded regulatory and quality services. Overlaps directly with JYA's Validation/Commissioning/Qualification and quality system remediation offerings.

Broad incumbents

• Parexel International: Global CRO offering comprehensive regulatory affairs, quality, and compliance consulting as part of broader drug development services. Represents the scaled-incumbent alternative to boutique firms like JYA for enterprise sponsors.
• IQVIA Regulatory & Quality: Global CRO and life sciences services firm with a substantial regulatory affairs and quality compliance practice. Competes with JYA for large enterprise pharma sponsors seeking integrated regulatory support.
• NSF International (Pharma Biotech): Large global organization with a dedicated pharma/biotech consulting practice covering quality, regulatory, and training services. A scaled incumbent offering overlapping capabilities as part of a broader portfolio, including training and certification programs.

Emerging players

• BioProcess Technology Consultants (BPTC): Bioprocess and CMC-focused consultancy serving biologics and gene therapy developers. Comparable to JYA's Drug Substance/API and biologics areas of expertise for cell and gene therapy sponsors.
• Vinet Consulting: Specialty pharma regulatory and quality consulting firm focused on small and mid-sized biotech. Overlaps with JYA in serving biologics, gene therapy, and cell therapy sponsors preparing for FDA interactions.
• RegDesk: Tech-enabled regulatory affairs and quality management platform for life sciences companies. Adjacent to JYA's traditional services but increasingly competing for the same pharma/biotech regulatory budget via software-driven delivery.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/jeff-yuen-&-associates-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jeff Yuen & Associates